Introduction
============

Diabetes: Definition and Description
------------------------------------

Diabetes mellitus is a group of metabolic diseases that are characterized by hyperglycemia and arise from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia, or raised blood sugar, is a common effect of uncontrolled diabetes, and this is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels ([@B169]).

There are two main types of diabetes, which are characterized by progressive β-cell death. Type 1 diabetes was previously known as insulin-dependent, juvenile or childhood-onset diabetes, and it is characterized by deficient insulin production that requires daily administration of insulin. This results from cellular-mediated autoimmune destruction of the β-cells of the pancreas. Type 2 diabetes was previously known as non-insulin-dependent or adult-onset diabetes, and it results from the ineffective use of insulin by the body. Several risk factors are known to be involved in the development of type 2 diabetes, including: genetic factors (i.e., family history), obesity, poor diet, insufficient physical activity, advancing age, ethnicity, high blood glucose during pregnancy, hypertension, and dyslipidemia ([@B116]; [@B83]; [@B108]; [@B33]).

Gestational diabetes represents a third class of diabetes, and this arises from glucose intolerance, with an onset during pregnancy. Women with gestational diabetes are at an increased risk of complications during pregnancy and at delivery. Although gestational diabetes is a temporary condition, it carries a long-term risk of type 2 diabetes ([@B23]).

According to the World Health Organization, an estimated 422 million adults were living with diabetes in 2014. In the adult population, the global prevalence of diabetes has nearly doubled since 1980. Over the past decade, diabetes prevalence has risen more rapidly in low-income and middle-income countries than in high-income countries. Diabetes caused 1.5 million deaths in 2012, with hyperglycemia causing an additional 2.2 million deaths, as it is associated with increased risk of cardiovascular and other diseases. Although separate global estimates of diabetes prevalence for type 1 and type 2 diabetes are not available, the majority of people with diabetes are affected by type 2 diabetes. Also of concern is that previously type 2 diabetes was diagnosed almost entirely among adults, while now it also occurs in children ([@B168]). Without effective prevention and management programs, further significant rises in diabetes will have grave consequences on the health and lifespan of the world population ([@B71]).

Oxidative stress is an acknowledged pathogenic mechanism in the development and progression of diabetes and its complications, which can arise as a result of increased free radical production and impaired antioxidant defenses ([@B29]; [@B107]; [@B89]; [@B164]). There are several known mechanisms whereby hyperglycemia contributes to the pathogenesis of diabetic complications: non-enzymatic glycosylation of proteins and lipids; protein kinase C activation; activation of the polyol pathway; and auto-oxidation of glucose ([@B21]; [@B29]; [@B107]; [@B11]).

Oxidative stress and other stresses caused by overnutrition (endoplasmic reticulum stress, lipotoxicity, and glucotoxicity) are thought to induce inflammatory response that plays an important role in the pathogenesis of type 2 diabetes ([@B144]; [@B43]; [@B172]). Recent studies have also shown the pathological involvement of the immune system in type 2 diabetes, that is, based on the presence of autoantibodies against β cells, self-reactive T cells and evidence of beneficial effect of some anti-inflammatory and immunomodulatory therapy, being viewed as an autoinflammatory disease ([@B73]). Nutritional interventions with food supplements as a form of complementary therapy in patients with diabetes are being used increasingly to counter these effects ([@B137]; [@B26]; [@B65]; [@B51]). In this review, botanicals that are most frequently promoted to help manage blood glucose levels and can be found marketed as food supplements promoting antidiabetic activity were selected and their mechanism of action described.

Food Supplements in Diabetes
----------------------------

Food supplements are concentrated sources of nutrients or other substances that can have nutritional or physiological effects, where the purpose is to supplement the normal diet. Food supplements are marketed in "dose" forms, such as pills, tablets, capsules, and liquids in measured doses. Supplements can be used to correct nutritional deficiencies or to maintain adequate intake of certain nutrients. However, in some cases excessive intake of vitamins and minerals might be harmful or cause unwanted side effects; therefore, indications for their maximum levels are necessary to ensure their safe use in food supplements ([@B47]). Recently, antioxidants have been extensively used to counter or overcome the effects of excess reactive oxygen species, which are involved in several pathologies, including diabetes and obesity. Another therapeutic approach for treating type 2 diabetes is the use of phytochemicals to lower the glucose absorption by inhibiting intestinal carbohydrate-hydrolysing enzymes α-amylase and α-glucosidase ([@B134]; [@B145]). Several phytochemicals were also been reported to reduce inflammatory compounds involved in the pathology of type 2 diabetes.

Herbal Products and Secondary Metabolites
=========================================

Herbal Products with Hyperglycemic Actions
------------------------------------------

Botanicals have been used for medicinal purposes through much of human history ([@B126]). Botanicals and their derived preparations made from plants, algae, fungi, and lichens have become widely available on the EU market in the form of food supplements ([@B46]).

Many pharmaceuticals commonly used today are structurally derived from the natural compounds that are found in traditional medicinal plants. For example, the development of the antihyperglycemic drug metformin can be traced to the traditional use of *Galega officinalis* to treat diabetes ([@B50]). Botanicals that are most frequently promoted to help manage blood glucose levels include bitter melon (*Momordica charantia*), fenugreek (*Trigonella foenum graecum*), gurmar (*Gymnema sylvestre*), ivy gourd (*Coccinia grandis*), nopal (*Opuntia* spp.), ginseng, Russian tarragon (*Artemisia dracunculus*), cinnamon (*Cinnamomum cassia*), psyllium (*Plantago ovata*), and garlic (*Allium sativum*) ([@B27]).

### Bitter Melon (*M. charantia* L.)

*Momordica charantia* is a climbing plant that belongs to the family Cucurbitaceae and is commonly known as bitter gourd or bitter melon. All parts of the plant have a bitter taste, including the fruit, which have a warty texture that resembles a small cucumber. *M. charantia* is cultivated throughout the tropics and subtropics ([@B59]). The main phytochemical constituents of bitter melon that have reported hypoglycemic actions are the cucurbitane-type triterpenoids charantin (a steroidal glycoside that is an equal mixture of stigmasterol glucoside and β-sitosterol glucoside), karaviloside IX, momordicoside S and its aglycones momordicosides A, B, Q, R, and T, and also polypeptide-p, vicine, and the ribosome-inactivating protein momordin ([@B152]; [@B79]). Several mechanisms of action have been proposed for the hypoglycemic actions of bitter melon extracts. Studies have shown that these can inhibit intestinal absorption of glucose ([@B59]; [@B31]), suppress key glucogenic enzymes ([@B139]), and decrease hepatic gluconeogenesis ([@B157]). It has been proposed that *M. charantia* enhances the activity of the AMP-activated protein kinase (AMPK) pathway (which is an important cellular regulator of lipid and glucose metabolism), and reduces expression of phosphoenolpyruvate carboxykinase (PEPCK; which results in reduced glucose levels; [@B141]). Polypeptide-p is sometimes referred as "plant insulin," and it is one of the few of these active compounds that have been studied in clinical trials. Polypeptide-p consists of 166 amino-acid residues and closely resembles bovine insulin ([@B85]; [@B45]). Polypeptide-p is a very effective hypoglycemic agent when administered subcutaneously ([@B79]). Clinical study investigating the effect of subcutaneous injection of polypeptide-p resulted in a statistically significant drop in mean blood sugar levels ([@B17]). Recent study demonstrated that administration of a cucurbitane-type triterpenoid isolated from *M. charantia* named compound K16 reduced blood glucose and blood lipids in murine model, while improving glucose tolerance. Compound K16 also upregulated the expression of several of insulin signaling pathway-associated proteins ([@B77]). Only a few randomized controlled trials of bitter melon have been conducted. According to [@B45] out of 21 reviewed studies less than 20% received a quality score of two or greater on the Jadad scale. Although evidence suggests possible beneficial effects of extracts of bitter melon and its active compounds in the prevention and control of diabetes, future clinical studies are needed to confirm this.

### Fenugreek (*T. foenum graecum* L.)

Fenugreek is a plant of the Fabaceae family that is native to India, China, and North Africa ([@B128]). The most studied bioactive compounds from fenugreek with reported hypoglycemic actions are diosgenin (3b-hydroxy-5-spirostene), 4-hydroxyisoleucine (**Figure [1](#F1){ref-type="fig"}**), and the soluble dietary fiber fraction of fenugreek seeds ([@B54]).
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Diosgenin in fenugreek is a major aglycone of saponin, and the reported hypoglycemic mechanisms of its action include renewal of pancreatic β-cells and stimulation of insulin secretion ([@B80]), antioxidative effects ([@B148]), and promotion of adipocyte differentiation and enhancement of insulin-dependent glucose uptake ([@B160]). 4-Hydroxyisoleucine is a branched-chain amino-acid derivative that is only found in plants, and it represents the majority of the total content of free amino acids in fenugreek seeds ([@B54]). It has been shown that the insulinotropic and antidiabetic properties of 4-hydroxyisoleucine act through stimulation of glucose-dependent insulin secretion and reduction of insulin resistance in muscle and/or liver ([@B75]). Fenugreek seeds are also a rich source of fiber (50--65 g fiber/100 g seeds). The soluble dietary fiber fraction of fenugreek (i.e., galactomannan) has been shown to enhance glycemic control. This effect has been attributed to inhibition of lipid-hydrolyzing and carbohydrate-hydrolyzing enzymes in the digestive system ([@B63]). Galactomannan also reduces the rate of glucose uptake through its actions as a significant physical barrier to glucose diffusion ([@B149]). Clinical studies reported that intake of fenugreek seeds significantly changed fasting blood glucose, 2 h postload glucose and hemoglobin A1c (HbA1c; [@B115]). Results of a recent study conducted on men and women with prediabetes strongly suggests that the enhancement of insulin levels is due to insulinotropic effect of fenugreek and suggest that the mode of action is a result of alkaloids present ([@B55]). Although results from clinical trials support beneficial effects of fenugreek seeds on glycemic control in persons with diabetes, trials with better methodology quality and well characterized preparation of sufficient dose are needed to provide more conclusive evidence. With its hypoglycemic and antidyslipidemic effects, fenugreek represents an attractive new candidate for treatment of type 2 diabetes, obesity, and dyslipidemia, the key components of metabolic syndrome.

### Gurmar \[*G. sylvestre* (Retz.) R.Br. ex Sm.\]

*Gymnema sylvestre* is a large woody climbing plant that grows in the dry forests of India. In Hindu folklore, chewing gymnema leaves results in the inability to taste sweetness. It is therefore also known as "gurmar," which means "destroyer of sugar" in Hindi ([@B173]). The active compounds that can be extracted from this plant are the gymnemic acids, of which there are several (gymnemic acids I--VII, gymnemosides A--F; [@B155]) and the gymnemasaponins ([@B94]; [@B87]). Another compound with sugar suppression activity that has been isolated from *G. sylvestre* is gurmarin, a 35-amino-acid peptide ([@B70]). The atomic arrangement of gymnemic acids on the taste buds are similar to that of sugar molecules, and therefore their binding to the receptors on the taste buds prevents receptor activation by the sugar molecules in the food, which prevents the taste of sweetness.

The proposed mechanisms for the hypoglycemic action of gymnemic acids might be increased secretion of insulin from the pancreas and promotion of islet cell regeneration ([@B19]). Gymnemic acids can also delay glucose absorption in the blood and prevent absorption of sugar molecules by the intestine, which leads to reductions in blood sugar levels ([@B155]). Although several studies have reported antidiabetic effects and sugar inactivation properties of gurmar ([@B90]; [@B98]; [@B81]), and recent interventional, randomized, double blind clinical study (NCT02370121) reported statistically significant reduction in body weight, reduced BMI and lower values for VLDV ([@B38]), clinical approval and scientific validation remain necessary before its use can be approved in the treatment of patients with diabetes.

### Ivy gourd \[*C. grandis* (L.) Voigt, syn. *Coccinia indica* Wight & Arn.\]

Ivy gourd (*C. grandis*) is a perennial creeper that belongs to the Cucurbitaceae family. It has been traditionally used in Ayurvedic practice as an antidiabetic drug. The proposed mechanism of action of *C. grandis* is not well understood, although it appears to be an insulin mimetic ([@B82]). Extracts of *C. grandis* are believed to have hypoglycemic effects through an insulin-secreting effect or through an influence on the enzymes involved in glucose metabolism ([@B125]). Despite the broad use of *C. grandis* in traditional medicine, very few systematic clinical studies have been reported to date that have examined its therapeutic properties. Human trials have shown that the active components of a *C. grandis* extract can reduce elevated levels of the enzymes glucose-6-phosphatase and lactase dehydrogenase in the glycolytic pathway, and restore lipoprotein lipase activity in the lipolytic pathway, with the control of hyperglycemia in diabetes ([@B67]; [@B82]; [@B92]). Double-blind clinical trial conducted on 61 healthy individuals showed statistically significant difference in postprandial blood sugar levels after 1 and 2 h confirming a blood sugar lowering effect of *C. grandis* ([@B114]). The data from animal and human trials are promising, and the reported hypoglycemic action of *C. grandis* might indicate its use as a dietary adjunct in the treatment of patients with diabetes.

### Nopal (*Opuntia* spp.)

The genus *Opuntia* is commonly known as prickly pear cactus, and this includes species that produce the nutritious fruit and young, edible cladodes (stem pads) that have been used for both nourishment and medicine for hundreds of years ([@B57]; [@B40]). The prickly pear cactus is traditionally used to treat diabetes in the form of a blended "shake" that is prepared from young cladodes ([@B22]). Nopal is rich in highly soluble fiber and pectin, which can affect intestinal glucose uptake, thus partly explaining its hypoglycemic actions ([@B53]; [@B50]). Several studies have confirmed that a total extract and a juice from the plant can have antihyperglycemic effects ([@B68]; [@B22]). Data from animal studies using extracts without fiber and pectin that have shown antihyperglycemic actions have suggested additional modes of action ([@B156]; [@B9]). Polysaccharide ODP-Ia has been isolated from *Opuntia dillenii* Haw., and this was shown to have antihyperglycemic effects through the protection of the liver from peroxidation damage and through the maintenance of tissue function, thereby improving the sensitivity of target cells to insulin ([@B176]). Recent study conducted on murine model suggested that *Opuntia ficus-indica* treatment acts by inhibiting glucose absorption from the intestine and enhancing glucose uptake from insulin-sensitive muscle cells through the AMPK/p38 MAPK signaling pathway ([@B96]). Findings of a recent study conducted on Mexican patients with type 2 diabetes suggest that *O. ficus-indica* (L.) Mill. could reduce postprandial blood glucose and serum insulin, as well as increase antioxidant activity in healthy people and patients with type 2 diabetes ([@B102]). Although preliminary human and animal trials have suggested that certain *Opuntia* species have hypoglycemic properties, more clinical studies are necessary to determine the true benefits of these plants as botanical interventions in the treatment of patients with type 2 diabetes.

### Ginseng: Korean or Asian ginseng (*Panax ginseng* C.A. Mey.) and American ginseng (*Panax quinquefolius* L.)

Out of 14 identified ginseng species to date, Korean red ginseng (*P. ginseng*) and American ginseng (*P. quinquefolius*) have been the most extensively used and studied ([@B37]). The part of the plant that is mainly used for medicinal purposes is the roots, although other parts are also being investigated for antidiabetic effects ([@B170]; [@B41]). The active components in ginseng include polysaccharides and polyacetylenes, although the majority of its pharmacological activity has been attributed to the ginsenosides, a group of triterpenoid saponins ([@B37]; [@B167]). Indeed, more than 150 naturally occurring ginsenosides have been isolated from the roots, leaves, stems, fruit, and flower heads of various *Panax* species ([@B37]). Several clinical trials and animal studies have demonstrated that ginseng and ginsenosides can lower blood glucose, to increase insulin sensitivity and regulate lipid metabolism ([@B36]; [@B165]). The proposed mechanism of the modulation of metabolic processes by ginsenosides is their activation of the peroxisome proliferator-activated receptors (PPARs) that regulate glucose and lipid metabolism, and the transcription of proteins involved in glucose and fatty-acid uptake ([@B14]). Recent studies have shown that ginsenosides activate AMPK pathway, resulting in suppression of hepatic gluconeogenesis and steatosis ([@B60]). Additional potential health effects of ginsenosides include anticarcinogenic, immunomodulatory, anti-inflammatory, anti-allergic, anti-atherosclerotic, antihypertensive, and antidiabetic effects, as well as effects on the central nervous system ([@B37]). Meta-analysis of 16 randomized controlled trials in people with and without diabetes concluded that ginseng modestly yet significantly improved fasting blood glucose in people with and without diabetes ([@B143]). For better assessment of ginseng's anti-diabetic efficacy, larger and longer randomized controlled clinical studies, using standardized ginseng preparations are warranted.

### Russian tarragon (*A. dracunculus* L.)

*Artemisia dracunculus* L., or Russian tarragon, is a perennial herb from the Asteraceae (daisy) family. French tarragon (which is also known as German tarragon) and Russian tarragon are the two main reported cultivars for this species ([@B118]). *A. dracunculus* has been widely used in traditional medicine because of its potential antimicrobial and antioxidant activities ([@B101]; [@B2]). The most important groups of biologically active secondary metabolites in *A. dracunculus* essential oils are coumarins, flavonoids, and phenolic acids ([@B118]). Several studies have reported antidiabetic effects of *A. dracunculus* ([@B58]; [@B86]; [@B132]; [@B1]). A study by [@B1] demonstrated that a well-characterized extract of *A. dracunculus* L. known as PMI-5011 can trigger insulin release from primary β-cells, as well as protect β-cells, which contributes to the preservation of metabolic homeostasis of insulin and β-cells. It has also been shown that PMI-5011 promotes decreased glucose and insulin levels in animal models and improves insulin signaling in primary human skeletal muscle cells ([@B86]; [@B117]; [@B161]). PMI-5011 treatment also led to an inhibition of cytokine-induced activation of inflammatory signaling pathways ([@B161]). Anti-inflammatory effect of ethanol extract was also demonstrated in murine model ([@B49]). These data indicate that this PMI-5011 *A. dracunculus* L. extract represents a promising botanical treatment for patients with diabetes. The most recent randomized, double blind, placebo-controlled clinical trial (NCT02330341) evaluating the effect of *A. dracunculus* on glycemic control, insulin sensitivity, and insulin secretion in patients with impaired glucose tolerance reported significantly decreased systolic blood pressure, glycated HbA1c, area under the curve of insulin, and total insulin secretion with a significant increase in HDL-C levels ([@B110]).

### Cinnamon (*Cinnamomum* spp.)

*Cinnamomum* (cinnamon) is a genus of the Lauraceae family. To date, about 250 species of cinnamon have been identified ([@B109]). Several preclinical and clinical investigations have demonstrated that extracts of cinnamon species can have antidiabetic activities, and have investigated their mechanism of action ([@B3]; [@B34]; [@B35]; [@B162]). The procyanidin oligomers are thought to be responsible for the antidiabetic activity of cinnamon ([@B103]; [@B34]). The mechanism behind the antidiabetic actions of cinnamon species is not fully understood yet. Different hypoglycemic effects have been reported for different cinnamon species. [@B34] reported that a *C. cassia* extract can promote lipid accumulation in adipose tissue and liver, whereas a *Cinnamomum tamala* (Buch.-Ham.) T. Nees & C.H. Eberm. extract mainly improved the insulin concentrations in the blood and pancreas. They defined the different antidiabetic effects according to the diverse procyanidin oligomer components in these extracts ([@B34]). Improved insulin resistance and lipid metabolism have been reported for a water extract of cinnamon, which was believed to be through activation of PPARs ([@B138]). Decreased gene expression of two major regulators of hepatic gluconeogenesis has been reported for a cinnamon water extract (i.e., PEPCK and glucose-6-phosphatase), as also reported for a murine model ([@B35]). Cinnamon also contains anti-inflammatory compounds that reduce production of prostaglandin-E2, interleukin 6 and nitric oxide (NO). *Trans*-cinnamaldehyde exhibited the strongest activity on NO production ([@B159]). A study on rat model of gestational diabetes showed hypoglycemic action of cinnamaldehyde by increasing insulin secretion and sensitivity through activating the antioxidant defense system, suppressing pro-inflammatory cytokines production and upregulating PPARγ gene expression ([@B66]). Review of clinical trials, evaluating the experimental evidence available for cinnamon in improving glycemic targets concluded that cinnamon has the potential to be a useful add-on therapy in the managing type 2 diabetes, but further trials are needed to establish its efficacy and safety ([@B109]). Data from different animal and human studies warrant continued investigations into the benefits of different cinnamon extracts supplementation on the prevention and treatment of type 2 diabetes and gestational diabetes.

### Garlic (*A. sativum* L.)

Garlic (*A. sativum*) is a member of the Amaryllidaceae family, along with onions, chives, and shallots ([@B69]). In addition to promoting total antioxidant levels and catalase activity, the antidiabetic potential of garlic includes: hyperinsulinemia, hypoglycemia, hypocholesterolemia, hypotriglyceridemia, and anti-glycation and anti-lipid-peroxidation actions ([@B154]). The active ingredients of garlic that have been attributed to its beneficial effects are mainly volatile sulfur compounds, like alliin (**Figure [2](#F2){ref-type="fig"}**), allicin, diallyl disulfide, diallyl trisulfide, diallyl sulfide, *S*-allyl cysteine, ajoene, and allyl mercaptan ([@B119]; [@B20]).

![Structure of alliin.](fphar-08-00436-g002){#F2}

Both fresh and aged garlic and its bioactive compounds have been extensively studied for their antihyperglycemic actions both in experimentally induced and genetic animal models of diabetes ([@B120]; [@B142]; [@B7]; [@B135]; [@B154]) and in human studies ([@B12]; [@B13]). Garlic has been shown to improve insulin sensitivity and the associated metabolic syndrome in animal models ([@B120]). Clinical trial studying the effect of oral administration of raw garlic on type 2 diabetic patients showed a significant reduction in blood glucose level, lipid metabolism and significant improvement in superoxide dismutase, catalase, and glutathione peroxidase in erythrocytes of diabetic patients ([@B112]). Several studies have also reported increased insulin secretion upon administration of garlic or garlic extracts/preparations ([@B48]; [@B99]). [@B72] speculated that the higher insulin production is a result of the actions of allixin, *S*-allyl cysteine sulfoxide, and diallyl trisulfide. Recent studies of *S*-allyl cysteine, the main organosulfur bioactive molecule in aged garlic extract, demonstrated its anti-diabetic, antioxidant, anti-inflammatory and neuroprotective properties ([@B18]; [@B174]). Studies in animal models and preliminary human studies have indicated beneficial effect of garlic and garlic extracts in the treatment of patients with diabetes and related metabolic disorders; however, more clinical trials are warranted to further explore the benefits of garlic for patients with type 2 diabetes.

### Psyllium (*P. ovata* Forssk.)

*Plantago* spp. belongs to the Plantaginaceae family, which comprises approximately 275 annual and perennial species that are distributed throughout the world. Some species are particularly valuable in the nutraceutical and pharmaceutical industries due to the mucilaginous product that is derived from the seed husk, which is known as psyllium ([@B56]). The most abundant polysaccharide in psyllium are the heteroxylans ([@B153]). Preparations obtained from seed husks of *P. ovata* are an excellent source of soluble fiber ([@B113]). As psyllium is less readily fermented, it causes fewer abdominal problems and it is better tolerated than other fiber supplements ([@B121]). The proposed glucose-lowering mechanisms of psyllium are: slowed access of glucose to the small intestine; delayed gastric emptying; and actions on carbohydrate digestion and absorption ([@B124]; [@B8]). Clinical study evaluating the effects of psyllium in type 2 diabetic patients reported significant decrease of glucose absorption and reduction of total and LDL cholesterol in the presence of psyllium, indicating its beneficial therapeutic effect in the metabolic control of type 2 diabetics ([@B146]).

### Ginger (*Zingiber officinale* Roscoe)

Ginger belongs to Zingiberaceae family and its rhizome is widely used as a spice all over the world. It has been traditionally used as herbal medicine to treat cancer, rheumatism, toothache, digestive health, and diabetes ([@B122]; [@B5]). Its components gingerols, shogaols, paradols, and zingiberene exhibit antioxidative effect, glucose and lipid lowering effects, as well as immunomodulatory, anti-inflammatory, antiapoptosis effect ([@B78]; [@B5]; [@B10]). The anti-inflammatory action of ginger is attributed to gingerols, shogaols, and diarylheptanoids that are thought to inhibit the activity of cyclooxygenase, inducible NO synthase and lipoxygenase suppress prostaglandin synthesis and interfere in cytokine signaling. Recent study reported improved insulin sensitivity and reduced total cholesterol and triglycerides as well as reduced C-reactive protein and prostaglandin E2 in patients with type 2 diabetes ([@B10]). A double-blind, placebo-controlled, randomized clinical trial conducted on patients with type 2 diabetes who did not receive insulin showed that ginger supplementation significantly reduced serum triglyceride and reported a minor beneficial effect on serum glucose ([@B140]).

Different studies revealed more than 100 plant species generally used for treatment of diabetes ([@B32]; [@B44]; [@B105]). The majority of the experiments confirmed their beneficial effect in the management of diabetes mellitus. Among the plants used for the diabetes, the most commonly studied species are described above, while other common plants used to treat diabetes that are available everywhere and their active phytochemicals are reported in **Table [1](#T1){ref-type="table"}**.

###### 

List of most common plants and their active phytochemicals having antidiabetic activity.

  Medicinal plant            Active phytochemical(s)                                                  Reference
  -------------------------- ------------------------------------------------------------------------ -----------------
  *Aegle marmelos*           Aegelin, coumarins, alkaloids                                            [@B32]
  *Allium cepa*              Allyl sulfide                                                            [@B32]
  *Aloe vera*                Aloin, aloe-emodin, pseudoprototinosaponin AIII, prototinosaponin AIII   [@B125]; [@B44]
  *Arctium lappa*            Sitosterol-beta-[D]{.smallcaps}-glucopyranoside                          [@B30]
  *Cannabis sativa*          Cannabinoids, cannabinol                                                 [@B32]; [@B42]
  *Lycium barbarum*          Polysaccharide                                                           [@B177]
  *Morus alba*               Moran A                                                                  [@B32]
  *Olea europaea*            Triterpenoids                                                            [@B44]
  *Oryza sativa*             Glycan                                                                   [@B32]
  *Psidium guajava*          Vescalagin, strictinin, isostrictinin, pedunculagin                      [@B125]; [@B44]
  *Punica granatum*          Gallic acid, ellagic acid                                                [@B52]
  *Stevia rebaudiana*        Stevioside                                                               [@B125]
  *Ziziphus spina-christi*   Christinin-A                                                             [@B125]

Secondary Metabolites
---------------------

### Plant Polyphenols

Polyphenols are a large and heterogeneous group of phytochemicals that can be found in plant-based foods, such as tea, coffee, wine, cocoa, cereal grains, legumes, fruit, and berries ([@B62]). Polyphenols are divided into flavonoids, phenolic acids, stilbenes, and lignans. Flavonoids can be further divided into flavones, flavonols, flavanols, flavanones, isoflavones, and anthocyanins ([@B106]). Evidence from numerous animal studies support antidiabetic properties for some of the dietary polyphenols, which suggests their potential for prevention and management of type 2 diabetes ([@B88]). Several mechanisms might contribute to their hypoglycemic effects, including: inhibition of carbohydrate digestion and glucose absorption in the intestine; stimulation of insulin secretion from pancreatic β-cells; modulation of glucose release from the liver; activation of insulin receptors and glucose uptake in insulin-sensitive tissues; and modulation of intracellular signaling pathways and gene expression ([@B62]; [@B16]).

#### Resveratrol

Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a phytoalexin that is naturally synthesized by plants as a defense mechanism that is triggered in response to infection and injury by fungi, bacteria, UV irradiation, and other plant stresses ([@B123]). Resveratrol is found in berries, grape skins, red wine, Japanese knotweed, peanuts, and roots of rhubarb ([@B88]), and it has two isomeric forms ([@B6]). Several studies have reported blood-glucose-lowering effects of resveratrol in animal models ([@B76]; [@B151]). Several mechanisms of the antidiabetic action of resveratrol have been reported: improvement of insulin sensitivity; enhancement of GLUT4 translocation; reduction in oxidative stress, regulation of carbohydrate-metabolizing enzymes; activation of sirtuin 1 (SIRT1) and AMPK; and reduction in the expression of adipogenic genes ([@B15]; [@B24]). The deacetylase activity of SIRT1 is believed to deacetylate and suppress Foxo1-induced transactivation of pyruvate dehydrogenase lipoamide kinase 4 (PDK4), a negative regulator of the glycolytic enzyme pyruvate dehydrogenase ([@B147]).

Although they have been limited to date, clinical studies combined with data from *in vitro* and animal studies have indicated the potential antidiabetic effects of resveratrol, as well as its effects on related metabolic disorders, although further studies are warranted specifically regarding its optimal doses ([@B166]).

#### Flavonoids

Flavonoids are secondary metabolites of plants and fungi that have a 15-carbon skeleton (**Figure [3](#F3){ref-type="fig"}**) that contains two phenyl rings and a heterocyclic ring, and they are primarily known as the pigments responsible for producing the many colors of flowers, fruit, and leaves ([@B84]). Several clinical and experimental studies have suggested that flavonoids have positive effects in the treatment, prevention, and alleviation of various diseases ([@B64]; [@B74]; [@B95]). The proposed mechanisms of action of flavonoids include antioxidant actions, central nervous system effects, alterations to gut transport, fatty-acid sequestration and processing, PPAR activation, and increased insulin sensitivity ([@B129]).

![General structure of the 15-carbon skeleton of flavonoids, which consists of two phenyl rings (A, B) and a heterocyclic ring (C).](fphar-08-00436-g003){#F3}

The anthocyanins are flavonoids that are of great nutritional interest as they are one of the major classes of the widely consumed dietary polyphenols in fruit and vegetables ([@B61]). They are especially abundant in dark-colored fruit, such as berries ([@B127]; [@B158]). Over the years, the antidiabetic potential of anthocyanin-rich foods has been well documented ([@B61]). A randomized, double-blinded, placebo-controlled clinical study reported by [@B150] showed that a daily dietary supplement with bioactives from whole blueberries promoted improved insulin sensitivity in obese, non-diabetic, and insulin-resistant participants. Several studies have been conducted to investigate the impact of the consumption of purified anthocyanins on the development and progression of type 2 diabetes mellitus (**Figure [4](#F4){ref-type="fig"}**). These have shown improvements to whole-body insulin sensitivity and significant reduction of fasting blood glucose ([@B150]), as well as increased serum adiponectin concentrations ([@B100]). It has been proposed that cyanidin 3-glucoside and its metabolite protocatechuic acid have insulin-like activities through regulation of internalization of glucose via the PPARγ signaling pathway. The increased PPARγ activity caused by cyanidin 3-glucoside resulted in upregulation of *Glut4* and translocation of GLUT4 to the membrane, as well as enhanced adiponectin secretion in human omental adipocytes ([@B136]). Numerous studies have suggested that anthocyanins target AMPK in skeletal muscle and liver, which results in increased glucose uptake and inhibition of gluconeogenesis ([@B91]). Simultaneously, acetyl-CoA carboxylase is inactivated and PPARα, acyl-CoA oxidase, and carnitine palmitoyltransferase-1A are upregulated in the liver, which leads to a reduction of the lipid content and enhanced insulin sensitivity ([@B158]).

![Proposed biological mechanisms underlying the actions of anthocyanins on hyperglycemia and insulin sensitivity. ACC, acetyl-CoA carboxylase; FA, fatty acid; Glc, glucose; GLUT4, glucose transporter 4; PEPCK, phosphoenolpyruvate carboxykinase.](fphar-08-00436-g004){#F4}

One of the limitations of anthocyanins compared to the other flavonoids is their relatively low bioavailability that varies depending on the food matrix, and on other antioxidants and macronutrients in the foods consumed, which consequently affect the absorption and antioxidant potential of anthocyanins ([@B171]). [@B28] proposed a strategy to overcome the limitations in anthocyanin delivery, using gastro-retentive systems that can promote sustained release of anthocyanins. The different structures and the heterogeneity of anthocyanins in berries and their health-promoting effects in synergy with other compounds warrant further studies to fully elucidate and understand the effects of anthocyanins in diabetes and on health in general ([@B127]). The majority of epidemiological studies have associated dietary polyphenols with lower risk of type 2 diabetes mellitus; however, these data have been inconsistent. Further well-designed studies are necessary before any specific health claims can be made.

Kaempferol, a dietary flavonol abundant in *Ginkgo biloba* L., grapefruit, broccoli, kale, tea, and many other edible plants. It was found to have anti-oxidant and anti-inflammatory effects in various disease models, including those for diabetes ([@B25]). Several mechanisms of its anti-diabetic action were reported. Kaempferol inhibits NF-κB pathway activation, thus inhibits hepatic inflammation, which is contributing to the improvement of insulin signaling defect in diabetes ([@B104]). Kaempferol was found to have protective effect on pancreatic β-cell. Its protective action is associated with improved cAMP signaling, inhibited cellular apoptosis ([@B175]). Oral administration of kaempferol decreased fasting blood glucose and improved insulin resistance ([@B163]). Other flavonoids with reported antidiabetic activity are naringin and naringenin, that are mainly found in various citrus fruits such as oranges and grapefruits ([@B4]). Several anti-diabetic mechanisms of naringenin were reported. In addition to its antioxidative potential and its inhibition of intestinal α-glucosidase it also exhibits insulin mimetic effect to decrease polyprotein B secretion ([@B130]; [@B163]; [@B133]). Naringin effects expression of hepatic genes involved in gluconeogenesis and lipid metabolism and thus prevents the development of metabolic syndrome by activating AMPK ([@B131]). One of the most widely used and widely distributed flavonols in human nutrition with reported anti-diabetic and anti-inflammatory activity is quercetin ([@B163]; [@B97]). Several mechanisms of its action include inhibition of intestinal glucose absorption by inhibition of GLUT2 ([@B93]), decrease of lipid peroxidation ([@B39]), inhibition of α-amylase and α-glucosidase ([@B111]). With the rapid increase of diabetes incidence, a need for effective phytochemicals with anti-diabetic activity rises. Given the increasing evidence of anti-diabetic activity of flavonoids, it is plausible that consumption of flavonoid-rich foods can reduce the risk of diabetes and that flavonoids can be the potential drugs of choice in management of diabetes mellitus.

Conclusion
==========

Many over-the-counter dietary supplements that still have insufficient medical information and supporting scientific evidence are used in the treatment of patients with diabetes and related metabolic disorders. In majority of the herbal products and secondary metabolites used in treating diabetes, the mechanisms of action involve regulation of insulin signaling pathways, translocation of GLUT-4 receptor and/or activation the PPARγ as well as anti-inflammatory and immunomodulatory action. Although numerous *in vitro* and *in vivo* studies, and a number of clinical studies, have reported beneficial effects of various extracts and preparations from plants, the data remain conflicting. The knowledge in this field is still limited and further studies into identifying active ingredients of several botanicals and their extracts with reported antidiabetic activity, as well as unveiling their mechanism of action, are needed. Since plants and their extracts constitute numerous active ingredients with unknown effect, caution is needed when interpreting and generalizing antidiabetic properties of such preparations. Synergistic effect of different phyto-derived constituents must also be considered. We must also take into consideration that many phytochemicals taken orally undergo considerable loss of bioactivity. Several novel delivery systems, based on natural materials, are already being developed to counter this problem and increase bioavailability of phyto-derived antidiabetic compounds. More studies are warranted to validate their efficacy and safety, and large, well-designed, randomized, double-blind, placebo-controlled, clinical studies need to be carried out before their use can be recommended for treatment and/or prevention of diabetes. As diabetes incidence increases, a need for effective phytochemicals with anti-diabetic activity increases and growing evidence of anti-diabetic activity of several plants or their constituents provides a great pool of potential effective and safe drug for prevention and management of diabetes.
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